Although its full substrate repertoire remains poorly defined—with only a handful of direct targets validated—DCLK1 modulates phosphorylation events that influence β-catenin, JNK, and downstream effectors in the MAPK and PI3K–AKT pathways, suggesting a broad role in cancer and tissue homeostasis. The gene discussed is DCLK1; the disease is cancer.